ASMB (Assembly Bio) Bathi saben saham sajrone rolas wulan pungkasan

Logo perusahaan publik Assembly Biosciences Inc (ASMB)

Assembly Biosciences (ASMB) delegates the synthesis of trial drug batches to external laboratories, flexibly rotating suppliers. The business relies on US-based R&D centers, outsourcing the production of small molecules against hepatitis B to contract manufacturing organizations. This chart of EPS (TTM) price action reflects a level of 97.80. The firm's strategy focuses on creating innovative agents that suppress viral replication, leveraging partners to optimize testing expenses.

assemblybio.com (ASMB): Bathi saben saham sajrone rolas wulan pungkasan saka 11.02.2024 nganti 12.11.2026

ASMB (Assembly Biosciences Inc): rincian analitis lan laporan miturut indikator

- rega pasar lan target rega analis:
- indikator valuasi pasar bisnis:
Analisis wiwitan perusahaan:ASMB (assemblybio.com)
Produk seri Assembly Biosciences

Year-over-year (TTM) EPS growth measures the dynamics of net income per share by comparing the current twelve-month period with the same period last year. Professionals utilize this rate to assess capitalization efficiency and the sustainability of cash flows. By analyzing historical year-over-year (TTM) EPS growth, an investor determines the fairness of a business's market value. For Assembly Biosciences (ASMB), this indicator is critical as it reflects financial viability amidst fierce competition with pharmaceutical behemoths.